News
Public · Published
Cigna Stock Has Gained Since Investor Day. Earnings Are Next. — Barrons.com
Cigna shares have gained nearly 11% since the company's Sept. 30 investor day, versus a 0.23% rise for the S&P 500. Investors are focused on specialty and care services as Cigna changes the revenue model for its pharmacy benefits business. Cigna expects specialty to provide more than 40% of total earnings by 2030, up from about 37% this year.
Published:
Updated:
What happened
Cigna shares have gained nearly 11% since the company’s Sept. 30 investor day, versus a 0.23% rise for the S&P 500. Investors are focused on specialty and care services as Cigna changes the revenue model for its pharmacy benefits business. Cigna expects specialty to provide more than 40% of total earnings by 2030, up from about 37% this year.
Confirmed
Global impact / market context
Specialty care treats complex conditions and uses drugs that often cost more and require intensive treatment. If this business grows as Cigna expects, it could become a larger source of earnings, making the company’s ability to expand services and manage pharmacy benefits revenue important to investors.
Analyst inference
Cigna’s shares have outperformed the S&P 500 since its investor day, but its third-quarter report is the next test. Analysts polled by FactSet expect adjusted earnings per share of $7.52, compared with $7.83 a year earlier; the article does not provide the reported result.
Confirmed
What to watch
- Cigna’s Thursday third-quarter report and adjusted earnings per share, with the FactSet estimate at $7.52 versus $7.83 in the same quarter last year. Confirmed
- Any update on the pharmacy benefits revenue model could clarify how Cigna plans to change revenue from that large business, though no details are provided here. Analyst inference
- Watch whether Cigna’s specialty business progresses toward its stated goal of more than 40% of total earnings by 2030, compared with about 37% this year. Confirmed
Evidence
- Original source link unavailable